Category: CONFERENCES

Conference: Replay of Advances in Mental Health. M-Vest & Maxim Group LLC.

One of the best Conferences we have viewed to date, and being on replay it can be viewed at your leisure and/or paused - for when your broker calls with...

Three Psychedelic Presentations Available Now: Filament Health (FLHLF), NovaMind (NVMDF) and Wesana Health (WSNAF)

Presentations Recorded September 16th Replays Available. Sign up for free registration to view presentations. https://youtu.be/e0ccytXLcEo The replays...

Maxim Mental Health and Psychedelic Conference

CLICK HERE Agenda 9:00 AM | AddictionFighting the pandemic within the pandemic John Bencich, Chief Executive Officer | Achieve Life Sciences...

On-Demand Now: Life Sciences Psychedelic Company Presentations.

The presentations from their recent live event are now available for replay. The event featured CEOs and top executives from international companies engaged in a wide range of initiatives across the...

Wonderland: Miami

November 8-9, 2021 Click to visit site

Small Pharma (DMT) To Present At Canaccord Genuity’s Annual Growth Conference

Progress in the development of DMT-assisted therapy for the treatment of depression LONDON, Aug. 9, 2021 /CNW/ -- Small Pharma Inc. (TSXV: DMT) (the "Company" or "Small Pharma"), a...

2023 Psychedelic Investor Conference

Coming Soon, Scheduled for Winter 2023 in Palm Beach County, FL the new Hedge Fund capital of...

Psychedelic Investor Conferences.

Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 – But Worth Considering! Cowen Psychedelics & Novel Mechanisms...
Most Popular

Awakn Life Sciences (AWKNF) $0.30 Announces Signing of Lease for Second Clinic in Norway.

Trondheim in central Norway will be the location of Awakn's 4th clinic LIVE QUOTE

Silo Pharma (SILO) Issues Letter to Shareholders

Silo Pharma Issues Letter to Shareholders Detailing Progress on Pipeline Assets Combining Traditional Therapeutics with Psychedelic Medicine LIVE QUOTE

Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates IND Enabling Study of Topical Ketamine Formulation

View Post ENGLEWOOD CLIFFS, NJ, Nov. 11, 2022 (GLOBE NEWSWIRE) -- Silo Pharma, Inc. (Nasdaq: SILO) (“the Company”), a developmental stage...